Viral contamination in biologic manufacture and implications for emerging therapies

Viral contamination in biologic manufacture and implications for emerging therapies

Recombinant protein therapeutics, vaccines, and plasma products have a long record of safety. However, the use of cell culture to produce recombinant proteins is still susceptible to contamination with viruses. These contaminations cost millions of dollars to recover from, can lead to patients not r...

Full description

Bibliographic Details
Main Authors: Barone, Paul, Wiebe, Michael E, Leung, James, Hussein, Islam, Keumurian, Flora J., Bouressa, James, Brussel, Audrey, Chen, Dayue, Chong, Ming, Dehghani, Houman, Gerentes, Lionel, Gilbert, James, Gold, Dan, Kiss, Robert, Kreil, Thomas R., Labatut, René, Li, Yuling, Müllberg, Jürgen, Mallet, Laurent, Menzel, Christian, Moody, Mark, Monpoeho, Serge, Murphy, Marie, Plavsic, Mark, Roth, Nathan J., Roush, David, Ruffing, Michael, Schicho, Richard, Snyder, Richard, Stark, Daniel, Zhang, Chun, Wolfrum, Jacqueline M, Sinskey, Anthony J, Springs, Stacy
Other Authors: Massachusetts Institute of Technology. Center for Biomedical Innovation
Format: Article
Language:English
Published: Springer Science and Business Media LLC 2021
Online Access:https://hdl.handle.net/1721.1/131201

Internet

https://hdl.handle.net/1721.1/131201

Similar Items